Pre-procedural antibody testing for SARS-CoV-2 in the routine endoscopic practice
- Alejandro Hernández Camba 1
- Raquel Marcelino Reyes 1
- Manuel Hernández Guerra 2
- O. A. Blasco 1
- Phillip Bennemann 1
- Natalia de la Riva 1
- Sara Diaz Machin 1
- José Alejandro Medina 1
- 1 Hospital Quironsalud Tenerife. Santa Cruz de Tenerife, Spain
- 2 Hospital Universitario Canarias. La Laguna, Santa Cruz de Tenerife. Spain
ISSN: 2340-416, 1130-0108
Año de publicación: 2021
Volumen: 113
Número: 2
Páginas: 116-118
Tipo: Artículo
Otras publicaciones en: Revista Española de Enfermedades Digestivas
Resumen
Methods: a retrospective multicenter cohort study was performed of all endoscopic procedures performed between April 27 and June 15, 2020. A screening questionnaire (SQ) was performed with patients three days prior to the procedure and 14 days after. Furthermore, a serologic SARS-CoV-2 test was performed 48 hours before. Results: two hundred and eleven consecutive patients with endoscopic procedures were included. No patients had a positive SQ, either on entry to the study or 14 days later. Only four patients (1.9 % [95 % CI: 0.07-4.8 %]) were positive for antibodies. Conclusion: the pre-endoscopy seroprevalence of SARS-CoV-2 is low in this cohort. Pre-procedural SARS-CoV-2 antibody testing does not add any benefit over clinical SQ to identify active COVID-19 patients.